Martin-Immanuel Bittner

Biography
Martin-Immanuel Bittner is the CEO of Arctoris, a biotech company combining wet lab automation and machine learning for accelerated small molecule drug discovery. Martin graduated as a medical doctor from the University of Freiburg in Germany, followed by his DPhil in Oncology as a Rhodes scholar at the University of Oxford, where he co-founded Arctoris. He has extensive research experience covering both clinical trials and preclinical drug discovery and is an active member of several leading cancer research organisations, including EACR, AACR, and ESTRO. Martin is a Fellow of the RSA and an elected member of the Young Academy of the German National Academy of Sciences and of Sigma Xi.